You are here

Harm reduction programming

As the global response to the HIV epidemic has developed it's clear that a combination of targetted prevention programming is needed to stabilise and reduce the number of new infections.

Harm reduction has gained more traction with policy- and programme makers in recent years, but coverage where it's most needed is severely lacking. 

In this section, we discuss some of the the main harm reduction initiatives including opioid substitution therapy and needle and syringe programmes, and what the future holds.

Last full review: 
05 April 2019
Next full review: 
04 April 2020
Image of the words harm reduction saves lives on back of hoodie
Harm reduction initiatives such as opioid substitution therapy reduce the risk of HIV among people who inject drugs.
Image of methadone dose
Opioid subsitution therapy programmes are delivered in a number of ways including primary care, specialist clinics, pharmacies and 'take home' OST. 
Image of needle exchange kit
Needle and syringe programmes are delivered in a number of ways including fixed sites, vending machines and at pharmacies.

Would you like to comment on this page?

 
1 Start 2 Complete

Please let us know any comments you have about the content on this page. Please note that we are unable to respond to any questions, or offer advice or information in relation to personal matters. We will not hold your personal data or use it for any other purpose. We are not able to acknowledge receipt of emails.

Last full review:
05 April 2019
Next full review:
04 April 2020